{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T20:34:51Z","timestamp":1790973291460,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T00:00:00Z","timestamp":1576713600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T00:00:00Z","timestamp":1576713600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Science Project of the Jiangsu Commission of Health","award":["H201515"],"award-info":[{"award-number":["H201515"]}]},{"name":"Science-Education Project of the Jiangsu Center for Disease Control and Prevention","award":["JKRC2011023"],"award-info":[{"award-number":["JKRC2011023"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Epidemiol"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s10654-019-00596-1","type":"journal-article","created":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T15:07:56Z","timestamp":1576768076000},"page":"363-370","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Vaccines and the risk of Guillain-Barr\u00e9 syndrome"],"prefix":"10.1007","volume":"35","author":[{"given":"Yong","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinlin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuhua","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanling","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fubao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,19]]},"reference":[{"key":"596_CR1","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.3346\/jkms.2017.32.7.1154","volume":"32","author":"YS Park","year":"2017","unstructured":"Park YS, Lee KJ, Kim SW, Kim KM, Suh BC. Clinical features of post-vaccination Guillain-Barr\u00e9 syndrome (GBS) in Korea. J Korean Med Sci. 2017;32:1154\u20139.","journal-title":"J Korean Med Sci"},{"key":"596_CR2","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s11882-011-0190-y","volume":"11","author":"TA Hardy","year":"2011","unstructured":"Hardy TA, Blum S, McCombe PA, Reddel SW. Guillain-Barr\u00e9 syndrome: modern theories of etiology. Curr Allergy Asthma Rep. 2011;11:197\u2013204.","journal-title":"Curr Allergy Asthma Rep"},{"key":"596_CR3","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1056\/NEJMra1114525","volume":"366","author":"N Yuki","year":"2012","unstructured":"Yuki N, Hartung HP. Guillain-Barr\u00e9 syndrome. N Engl J Med. 2012;366:2294\u2013304.","journal-title":"N Engl J Med"},{"key":"596_CR4","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0140-6736(05)67665-9","volume":"366","author":"RA Hughes","year":"2005","unstructured":"Hughes RA, Cornblath DR. Guillain-Barr\u00e9 syndrome. Lancet. 2005;366:1653\u201366.","journal-title":"Lancet"},{"key":"596_CR5","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S1473-3099(10)70140-7","volume":"10","author":"HC Lehmann","year":"2010","unstructured":"Lehmann HC, Hartung HP, Kieseier BC, Hughes RA. Guillain-Barr\u00e9 syndrome after exposure to influenza virus. Lancet Infect Dis. 2010;10:643\u201351.","journal-title":"Lancet Infect Dis"},{"key":"596_CR6","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1212\/WNL.51.4.1110","volume":"51","author":"BC Jacobs","year":"1998","unstructured":"Jacobs BC, Rothbarth PH, van der Meche FG, Herbrink P, Schmitz PI, de Klerk MA, et al. The spectrum of antecedent infections in Guillain-Barr\u00e9 syndrome: a case\u2013control study. Neurology. 1998;51:1110\u20135.","journal-title":"Neurology"},{"key":"596_CR7","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.3201\/eid1212.051032","volume":"12","author":"CC Tam","year":"2006","unstructured":"Tam CC, O'Brien SJ, Rodrigues LC. Influenza, Campylobacter and Mycoplasma infections, and hospital admissions for Guillain-Barr\u00e9 syndrome, England. Emerg Infect Dis. 2006;12:1880\u20137.","journal-title":"Emerg Infect Dis"},{"key":"596_CR8","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S0140-6736(16)00562-6","volume":"387","author":"VM Cao-Lormeau","year":"2016","unstructured":"Cao-Lormeau VM, Blake A, Mons S, Lastere S, Roche C, Vanhomwegen J, et al. Guillain-Barr\u00e9 syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet. 2016;387:1531\u20139.","journal-title":"Lancet"},{"key":"596_CR9","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz625","author":"S Stegmann-Planchard","year":"2019","unstructured":"Stegmann-Planchard S, Gallian P, Tressieres B, Leparc-Goffart I, Lannuzel A, Signate A, et al. Chikungunya, a risk factor for Guillain-Barr\u00e9 syndrome. Clin Infect Dis. 2019. https:\/\/doi.org\/10.1093\/cid\/ciz625.","journal-title":"Clin Infect Dis."},{"key":"596_CR10","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jns.2017.02.024","volume":"375","author":"FL Hiew","year":"2017","unstructured":"Hiew FL, Rajabally YA. Malignancy in Guillain-Barr\u00e9 syndrome: a twelve-year single-center study. J Neurol Sci. 2017;375:275\u20138.","journal-title":"J Neurol Sci"},{"key":"596_CR11","doi-asserted-by":"crossref","first-page":"e1220","DOI":"10.1212\/WNL.0000000000006246","volume":"91","author":"J Rudant","year":"2018","unstructured":"Rudant J, Dupont A, Mikaeloff Y, Bolgert F, Coste J, Weill A. Surgery and risk of Guillain-Barr\u00e9 syndrome: a French nationwide epidemiologic study. Neurology. 2018;91:e1220\u2013e12271227.","journal-title":"Neurology"},{"key":"596_CR12","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/oxfordjournals.aje.a112795","volume":"110","author":"LB Schonberger","year":"1979","unstructured":"Schonberger LB, Bregman DJ, Sullivan-Bolyai JZ, Keenlyside RA, Ziegler DW, Retailliau HF, et al. Guillain-Barr\u00e9 syndrome following vaccination in the National Influenza Immunization Program, United States, 1976\u20131977. Am J Epidemiol. 1979;110:105\u201323.","journal-title":"Am J Epidemiol"},{"key":"596_CR13","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2165\/00002018-200932040-00005","volume":"32","author":"P Haber","year":"2009","unstructured":"Haber P, Sejvar J, Mikaeloff Y, DeStefano F. Vaccines and Guillain-Barr\u00e9 syndrome. Drug Saf. 2009;32:309\u201323.","journal-title":"Drug Saf"},{"key":"596_CR14","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1136\/bmj.312.7044.1475d","volume":"312","author":"R Hughes","year":"1996","unstructured":"Hughes R, Rees J, Smeeton N, Winer J. Vaccines and Guillain-Barr\u00e9 syndrome. BMJ. 1996;312:1475\u20136.","journal-title":"BMJ"},{"key":"596_CR15","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1097\/00007611-198708000-00028","volume":"80","author":"N Newton Jr","year":"1987","unstructured":"Newton N Jr, Janati A. Guillain-Barr\u00e9 syndrome after vaccination with purified tetanus toxoid. South Med J. 1987;80:1053\u20134.","journal-title":"South Med J"},{"key":"596_CR16","first-page":"767","volume":"22","author":"M Khamaisi","year":"2004","unstructured":"Khamaisi M, Shoenfeld Y, Orbach H. Guillain-Barr\u00e9 syndrome following hepatitis B vaccination. Clin Exp Rheumatol. 2004;22:767\u201370.","journal-title":"Clin Exp Rheumatol"},{"key":"596_CR17","first-page":"87","volume":"55","author":"A Siddiqui","year":"2005","unstructured":"Siddiqui A, Usmani RI, Anwer S, Afsar S. Guillain-Barr\u00e9 syndrome occurring after rabies vaccination. JPMA J Pak Med Assoc. 2005;55:87\u20138.","journal-title":"JPMA J Pak Med Assoc"},{"key":"596_CR18","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/aje\/kws195","volume":"175","author":"SK Greene","year":"2012","unstructured":"Greene SK, Rett M, Weintraub ES, Li L, Yin R, Amato AA, et al. Risk of confirmed Guillain-Barr\u00e9 syndrome following receipt of monovalent inactivated influenza A (H1N1) and seasonal influenza vaccines in the Vaccine Safety Datalink Project, 2009\u20132010. Am J Epidemiol. 2012;175:1100\u20139.","journal-title":"Am J Epidemiol"},{"key":"596_CR19","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/ene.12265","volume":"21","author":"Y Chen","year":"2014","unstructured":"Chen Y, Ma F, Zhang J, Chu X, Xu Y. Population incidence of Guillain-Barr\u00e9 syndrome in parts of China: three large populations in Jiangsu province, 2008\u20132010. Eur J Neurol. 2014;21:124\u20139.","journal-title":"Eur J Neurol"},{"key":"596_CR20","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.vaccine.2010.06.003","volume":"29","author":"JJ Sejvar","year":"2011","unstructured":"Sejvar JJ, Kohl KS, Gidudu J, Amato A, Bakshi N, Baxter R, et al. Guillain-Barr\u00e9 syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine. 2011;29:599\u2013612.","journal-title":"Vaccine"},{"key":"596_CR21","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1212\/WNL.0b013e3181e07d14","volume":"74","author":"L Ruts","year":"2010","unstructured":"Ruts L, Drenthen J, Jacobs BC, van Doorn PA, Dutch GBSSG. Distinguishing acute-onset CIDP from fluctuating Guillain-Barr\u00e9 syndrome: a prospective study. Neurology. 2010;74:1680\u20136.","journal-title":"Neurology"},{"key":"596_CR22","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/oxfordjournals.aje.a116813","volume":"138","author":"G Maldonado","year":"1993","unstructured":"Maldonado G, Greenland S. Simulation study of confounder-selection strategies. Am J Epidemiol. 1993;138:923\u201336.","journal-title":"Am J Epidemiol"},{"key":"596_CR23","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/aje\/kwn310","volume":"169","author":"J Stowe","year":"2009","unstructured":"Stowe J, Andrews N, Wise L, Miller E. Investigation of the temporal association of Guillain-Barr\u00e9 syndrome with influenza vaccine and influenza like illness using the United Kingdom General Practice Research Database. Am J Epidemiol. 2009;169:382\u20138.","journal-title":"Am J Epidemiol"},{"key":"596_CR24","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.2105\/AJPH.2011.300510","volume":"102","author":"DR Burwen","year":"2012","unstructured":"Burwen DR, Sandhu SK, MaCurdy TE, Kelman JA, Gibbs JM, Garcia B, et al. Surveillance for Guillain-Barr\u00e9 syndrome after influenza vaccination among the Medicare population, 2009\u20132010. Am J Public Health. 2012;102:1921\u20137.","journal-title":"Am J Public Health"},{"key":"596_CR25","doi-asserted-by":"crossref","first-page":"e67185","DOI":"10.1371\/journal.pone.0067185","volume":"8","author":"SK Greene","year":"2013","unstructured":"Greene SK, Rett MD, Vellozzi C, Li L, Kulldorff M, Marcy SM, et al. Guillain-Barr\u00e9 syndrome, influenza vaccination, and antecedent respiratory and gastrointestinal infections: a case-centered analysis in the vaccine safety datalink, 2009\u20132011. PLoS ONE. 2013;8:e67185.","journal-title":"PLoS ONE"},{"key":"596_CR26","doi-asserted-by":"crossref","first-page":"7878","DOI":"10.1016\/j.vaccine.2011.08.069","volume":"29","author":"N Andrews","year":"2011","unstructured":"Andrews N, Stowe J, Al-Shahi Salman R, Miller E. Guillain-Barr\u00e9 syndrome and H1N1 (2009) pandemic influenza vaccination using an AS03 adjuvanted vaccine in the United Kingdom: self-controlled case series. Vaccine. 2011;29:7878\u201382.","journal-title":"Vaccine"},{"key":"596_CR27","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1136\/archdischild-2013-304475","volume":"99","author":"C Verity","year":"2014","unstructured":"Verity C, Stellitano L, Winstone AM, Stowe J, Andrews N, Miller E. Pandemic A\/H1N1 2009 influenza vaccination, preceding infections and clinical findings in UK children with Guillain-Barr\u00e9 syndrome. Arch Dis Child. 2014;99:532\u20138.","journal-title":"Arch Dis Child"},{"key":"596_CR28","doi-asserted-by":"crossref","first-page":"d3908","DOI":"10.1136\/bmj.d3908","volume":"343","author":"J Dieleman","year":"2011","unstructured":"Dieleman J, Romio S, Johansen K, Weibel D, Bonhoeffer J, Sturkenboom M, et al. Guillain-Barr\u00e9 syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case-control study in Europe. BMJ. 2011;343:d3908.","journal-title":"BMJ"},{"key":"596_CR29","doi-asserted-by":"crossref","first-page":"574","DOI":"10.5694\/mja12.10534","volume":"197","author":"NW Crawford","year":"2012","unstructured":"Crawford NW, Cheng A, Andrews N, Charles PG, Clothier HJ, Day B, et al. Guillain-Barr\u00e9 syndrome following pandemic (H1N1) 2009 influenza A immunisation in Victoria: a self-controlled case series. Med J Aust. 2012;197:574\u20138.","journal-title":"Med J Aust"},{"key":"596_CR30","doi-asserted-by":"crossref","first-page":"e82222","DOI":"10.1371\/journal.pone.0082222","volume":"9","author":"S Romio","year":"2014","unstructured":"Romio S, Weibel D, Dieleman JP, Olberg HK, de Vries CS, Sammon C, et al. Guillain-Barr\u00e9 syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccines: a multinational self-controlled case series in Europe. PLoS ONE. 2014;9:e82222.","journal-title":"PLoS ONE"},{"key":"596_CR31","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/S0140-6736(12)62189-8","volume":"381","author":"DA Salmon","year":"2013","unstructured":"Salmon DA, Proschan M, Forshee R, Gargiullo P, Bleser W, Burwen DR, et al. Association between Guillain-Barr\u00e9 syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis. Lancet. 2013;381:1461\u20138.","journal-title":"Lancet"},{"key":"596_CR32","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.1016\/j.vaccine.2013.06.032","volume":"31","author":"CN Dodd","year":"2013","unstructured":"Dodd CN, Romio SA, Black S, Vellozzi C, Andrews N, Sturkenboom M, et al. International collaboration to assess the risk of Guillain Barre syndrome following Influenza A (H1N1) 2009 monovalent vaccines. Vaccine. 2013;31:4448\u201358.","journal-title":"Vaccine."},{"key":"596_CR33","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1016\/j.vaccine.2015.05.013","volume":"33","author":"LH Martin Arias","year":"2015","unstructured":"Martin Arias LH, Sanz R, Sainz M, Treceno C, Carvajal A. Guillain-Barr\u00e9 syndrome and influenza vaccines: a meta-analysis. Vaccine. 2015;33:3773\u20138.","journal-title":"Vaccine"},{"key":"596_CR34","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1001\/jama.2012.7342","volume":"308","author":"P De Wals","year":"2012","unstructured":"De Wals P, Deceuninck G, Toth E, Boulianne N, Brunet D, Boucher RM, et al. Risk of Guillain-Barr\u00e9 syndrome following H1N1 influenza vaccination in Quebec. JAMA. 2012;308:175\u201381.","journal-title":"JAMA"},{"key":"596_CR35","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/pds.3638","volume":"23","author":"J Prestel","year":"2014","unstructured":"Prestel J, Volkers P, Mentzer D, Lehmann HC, Hartung HP, Keller-Stanislawski B, et al. Risk of Guillain-Barr\u00e9 syndrome following pandemic influenza A(H1N1) 2009 vaccination in Germany. Pharmacoepidemiol Drug Saf. 2014;23:1192\u2013204.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"596_CR36","doi-asserted-by":"crossref","first-page":"696","DOI":"10.2105\/AJPH.2013.301651","volume":"104","author":"C Vellozzi","year":"2014","unstructured":"Vellozzi C, Iqbal S, Stewart B, Tokars J, DeStefano F. Cumulative risk of Guillain-Barr\u00e9 syndrome among vaccinated and unvaccinated populations during the 2009 H1N1 influenza pandemic. Am J Public Health. 2014;104:696\u2013701.","journal-title":"Am J Public Health"},{"key":"596_CR37","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1212\/WNL.39.8.1034","volume":"39","author":"E Kinnunen","year":"1989","unstructured":"Kinnunen E, Farkkila M, Hovi T, Juntunen J, Weckstrom P. Incidence of Guillain-Barr\u00e9 syndrome during a nationwide oral poliovirus vaccine campaign. Neurology. 1989;39:1034\u20136.","journal-title":"Neurology"},{"key":"596_CR38","first-page":"1120","volume":"55","author":"Centers for Disease C, Prevention","year":"2006","unstructured":"Centers for Disease C, Prevention. Update: Guillain-Barr\u00e9 syndrome among recipients of Menactra meningococcal conjugate vaccine\u2014United States, June 2005\u2013September 2006. MMWR Morb Mortal Wkly Rep. 2006;55:1120\u20134.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"596_CR39","unstructured":"Stratton K, Ford A, Rusch E, Clayton EW, editors. IOM (Institute of Medicine). Adverse effects of vaccines: evidence and causality. Washington, DC: National Academies Press; 2011. p 334."},{"key":"596_CR40","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jns.2016.03.008","volume":"364","author":"J Ishii","year":"2016","unstructured":"Ishii J, Yuki N, Kawamoto M, Yoshimura H, Kusunoki S, Kohara N. Recurrent Guillain-Barr\u00e9 syndrome, Miller Fisher syndrome and Bickerstaff brainstem encephalitis. J Neurol Sci. 2016;364:59\u201364.","journal-title":"J Neurol Sci"},{"key":"596_CR41","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.2008.156463","volume":"80","author":"K Kuitwaard","year":"2009","unstructured":"Kuitwaard K, van Koningsveld R, Ruts L, Jacobs BC, van Doorn PA. Recurrent Guillain-Barr\u00e9 syndrome. J Neurol Neurosurg Psychiatry. 2009;80:56\u20139.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"596_CR42","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1600-0404.2012.01667.x","volume":"126","author":"N Mossberg","year":"2012","unstructured":"Mossberg N, Nordin M, Movitz C, Nilsson S, Hellstrand K, Bergstrom T, et al. The recurrent Guillain-Barr\u00e9 syndrome: a long-term population-based study. Acta Neurol Scand. 2012;126:154\u201361.","journal-title":"Acta Neurol Scand"},{"issue":"Pt 4","key":"596_CR43","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1093\/brain\/115.4.1093","volume":"115","author":"F Grand'Maison","year":"1992","unstructured":"Grand'Maison F, Feasby TE, Hahn AF, Koopman WJ. Recurrent Guillain-Barr\u00e9 syndrome. Clinical and laboratory features. Brain J Neurol. 1992;115(Pt 4):1093\u2013106.","journal-title":"Brain J Neurol"},{"key":"596_CR44","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1136\/jnnp.73.3.348","volume":"73","author":"J Pritchard","year":"2002","unstructured":"Pritchard J, Mukherjee R, Hughes RA. Risk of relapse of Guillain-Barr\u00e9 syndrome or chronic inflammatory demyelinating polyradiculoneuropathy following immunisation. J Neurol Neurosurg Psychiatry. 2002;73:348\u20139.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"596_CR45","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1529-8027.2009.00243.x","volume":"14","author":"K Kuitwaard","year":"2009","unstructured":"Kuitwaard K, Bos-Eyssen ME, Blomkwist-Markens PH, van Doorn PA. Recurrences, vaccinations and long-term symptoms in GBS and CIDP. J Peripher Nerv Syst JPNS. 2009;14:310\u20135.","journal-title":"J Peripher Nerv Syst JPNS."},{"key":"596_CR46","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1086\/589624","volume":"198","author":"I Nachamkin","year":"2008","unstructured":"Nachamkin I, Shadomy SV, Moran AP, Cox N, Fitzgerald C, Ung H, et al. Anti-ganglioside antibody induction by swine (A\/NJ\/1976\/H1N1) and other influenza vaccines: insights into vaccine-associated Guillain-Barr\u00e9 syndrome. J Infect Dis. 2008;198:226\u201333.","journal-title":"J Infect Dis"},{"key":"596_CR47","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000184748","volume":"32","author":"A McGrogan","year":"2009","unstructured":"McGrogan A, Madle GC, Seaman HE, de Vries CS. The epidemiology of Guillain-Barr\u00e9 syndrome worldwide. A systematic literature review. Neuroepidemiology. 2009;32:150\u201363.","journal-title":"Neuroepidemiology"},{"key":"596_CR48","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/088307380001500308","volume":"15","author":"AK Asbury","year":"2000","unstructured":"Asbury AK. New concepts of Guillain-Barr\u00e9 syndrome. J Child Neurol. 2000;15:183\u201391.","journal-title":"J Child Neurol"},{"issue":"Pt 3","key":"596_CR49","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/brain\/118.3.577","volume":"118","author":"JW Griffin","year":"1995","unstructured":"Griffin JW, Li CY, Ho TW, Xue P, Macko C, Gao CY, et al. Guillain-Barr\u00e9 syndrome in northern China. The spectrum of neuropathological changes in clinically defined cases. Brain J Neurol. 1995;118(Pt 3):577\u201395.","journal-title":"Brain J Neurol"},{"key":"596_CR50","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1007\/s10067-014-2846-1","volume":"34","author":"DA Geier","year":"2015","unstructured":"Geier DA, Geier MR. A case\u2013control study of quadrivalent human papillomavirus vaccine-associated autoimmune adverse events. Clin Rheumatol. 2015;34:1225\u2013311.","journal-title":"Clin Rheumatol"}],"container-title":["European Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10654-019-00596-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10654-019-00596-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10654-019-00596-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,18]],"date-time":"2020-12-18T00:45:46Z","timestamp":1608252346000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10654-019-00596-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,19]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["596"],"URL":"https:\/\/doi.org\/10.1007\/s10654-019-00596-1","relation":{},"ISSN":["0393-2990","1573-7284"],"issn-type":[{"value":"0393-2990","type":"print"},{"value":"1573-7284","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,19]]},"assertion":[{"value":"10 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}